VERICEL CORPORATION Investment Warrants, Exercise Price
VERICEL CORPORATION (VCEL) reported Investment Warrants, Exercise Price of $4.27 for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-05.
Discontinued › Notes
invest:InvestmentWarrantsExercisePrice · last filed 2019-11-05
- 2019-09-30: Investment Warrants, Exercise Price 9 month $4.27.
USD
| Period end | Investment Warrants, Exercise Price 9 month |
|---|---|
| 2019-09-30 | $4.27 10-Q · filed 2019-11-05 |
USD/shares
| Period end | Investment Warrants, Exercise Price 9 month |
|---|---|
| 2019-09-30 | $4.27 10-Q · filed 2019-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |